The solubility of 2, 2-azobisisobutyronitrile (AIBN) in pure methanol, ethanol, acetone, benzene, ethyl acetate and a mixture of methanol and water was measured in the temperature range from 268.15 K to 325.15 K at atmospheric pressure. The AIBN solubility was sensitive to the temperature in all the pure solvents. The solubility in the binary mixture of methanol and water increased as the methanol fraction and temperature increased. The data were correlated with the modified Apelblat equation, Van't Hoff equation and Buchowski-Ksiazczak h equation. Other results showed two AIBN polymorphs formed after the crystallization, form I, in a monoclinic cell, and form II, in a triclinic cell, which confirmed the two AIBN crystal structures reported in the literature. Additionally, the initial concentration and cooling rate of the AIBN crystallization had dominant roles in affecting the polymorphic forms of the AIBN crystals. The crystallization conditions were optimized in a 2 L crystallizer to yield crystals with the desired morphology and polymorphs, which resolved the caking issue experienced in the industrial production of AIBN. The optimized conditions were tested in a 20 L crystallizer.
The problem of non-fragile memoryless controller design for a class of uncertain nonlinear stochastic system with time-delay is considered. Based on Lyapunov candidate and the stochastic Lyapunov stability theory, the sufficient conditions making the closed-loop system robust stable are given and de-rived. All results are given by the form of linear matrix inequality (LMI) method. Numerical example is given to illustrate the effectiveness of the controller designed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.